Financial Performance - The company's operating revenue for Q1 2022 was ¥779,303,894.35, representing a 44.60% increase compared to the same period last year[6] - Net profit attributable to shareholders was ¥10,309,654.40, with a basic earnings per share of ¥0.026[6] - Total operating revenue for Q1 2022 was CNY 779,303,894.35, an increase of 44.6% compared to CNY 538,940,272.89 in Q1 2021[34] - Net profit for Q1 2022 was CNY 12,567,672.85, a significant recovery from a net loss of CNY 16,331,560.12 in Q1 2021[36] - Earnings per share for Q1 2022 was CNY 0.026, compared to a loss per share of CNY 0.047 in Q1 2021[36] - The total comprehensive income for Q1 2022 was CNY 13,111,905.06, recovering from a loss of CNY 30,369,215.78 in Q1 2021[36] Cash Flow - The company reported a net cash flow from operating activities of -¥77,776,972.67, indicating a cash outflow[6] - Cash inflow from operating activities for Q1 2022 was approximately CNY 1.17 billion, up from CNY 821.47 million in Q1 2021, representing a year-over-year increase of 42.9%[41] - Net cash outflow from operating activities was CNY -77.78 million, an improvement compared to CNY -255.94 million in the same period last year[41] - Cash inflow from financing activities was CNY 560.38 million, significantly higher than CNY 348.16 million in Q1 2021, marking an increase of 60.8%[42] - Net cash flow from financing activities was CNY 236.20 million, compared to CNY 62.16 million in the same quarter last year, showing a substantial increase of 279.5%[42] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,695,982,135.97, showing a 0.99% increase from the end of the previous year[8] - Total liabilities increased to CNY 3,235,493,447.04 in Q1 2022 from CNY 3,204,843,455.54 in Q1 2021[30] - Current liabilities totaled ¥3,028,002,363.42, a marginal increase from ¥3,024,465,662.93, indicating stability in short-term obligations[29] - Long-term borrowings rose to ¥193,574,365.90 from ¥166,594,507.48, reflecting an increase of approximately 16.2%[29] Research and Development - Research and development expenses totaled ¥117,172,878.83, accounting for 15.04% of operating revenue, a decrease of 7.25 percentage points year-on-year[8] - Research and development expenses for Q1 2022 were CNY 117,172,878.83, slightly down from CNY 120,124,311.53 in Q1 2021[34] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 4,245, with the top ten shareholders holding a combined 38.44% of shares[16] - Total equity attributable to shareholders of the parent company rose to CNY 2,421,368,046.25 in Q1 2022 from CNY 2,398,550,263.71 in Q1 2021[30] Inventory and Accounts Receivable - Accounts receivable decreased to ¥1,370,978,310.08 from ¥1,662,940,439.36, reflecting a decline of about 17.5%[26] - Inventory increased to ¥2,552,873,079.84 from ¥2,216,310,373.75, indicating a rise of approximately 15.1%[26] - The company reported a significant decrease in accounts receivable financing by 68.62%, mainly due to increased endorsements of notes receivable[10] Other Observations - The company has not reported any significant changes in its financing activities or major strategic shifts during the reporting period[24] - There are no indications of new product launches or technological advancements mentioned in the current report[24] - The company has not disclosed any new product or technology developments, market expansion, or acquisition strategies in the provided financial data[43]
博众精工(688097) - 2022 Q1 - 季度财报